PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
暂无分享,去创建一个
Z. Szallasi | K. Mouw | A. Choudhury | Z. Sztupinszki | S. Rafiei | R. Bekele | Kasia M. Dillon | Timothy Hanlon
暂无分享,去创建一个
Z. Szallasi | K. Mouw | A. Choudhury | Z. Sztupinszki | S. Rafiei | R. Bekele | Kasia M. Dillon | Timothy Hanlon